With continued research and development, these drugs could become a standard treatment for obesity and other chronic diseases
This one number decides every unit you draw
Closing the gap between employee needs and benefits GLP-1 medications are influencing how employees think about their health and their employment
JAMA points out that "these adverse events, although rare, must be considered by patients who are thinking about using the drugs for weight loss because the risk-benefit calculus for this group might differ from that of those who use them for diabetes" [20]
By when can you expect to see results
Brands like Nestl and ADM were among the first to market GLP-1-friendly products last year, entering through supplements, beverages, snacks, and gummies